Design Therapeutics, Inc. (DSGN)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Design Therapeutics, Inc. (DSGN)
Company Performance

Current Price

as of Oct 18, 2024

$5.59

P/E Ratio

N/A

Market Cap

$316.79M

Description

Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease. The company was founded by Pratik Shah and Aseem Z. Ansari on December 18, 2017 and is headquartered in Carlsbad, CA.

Metrics

Overview

  • HQCarlsbad, CA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerDSGN
  • Price$5.595-7.06%

Trading Information

  • Market Cap$316.79M
  • Float56.70%
  • Average Daily Volume (1m)191,096
  • Average Daily Volume (3m)277,515
  • EPS-$0.90

Company

  • RevenueN/A
  • Rev Growth (1yr)N/A
  • Net Income-$11.79M
  • Gross MarginN/A
  • EBITDA MarginN/A
  • EBITDA-$14.89M
  • EV-$68.85M
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
  • P/B1.21
Documents